XFLT Hands the Keys to King Street — and Pays for Its Discount in Tenders
A $566 million CLO trust replaces Octagon with Rockford Tower, buys ABS and European CLOs, and answers nine months of buyback demands with a three-stage tender program — while CLO equity still trades at 40 cents on the dollar
XFLT · Earnings Call · 2026-11-02
The Handoff Nobody Advertised Until It Happened
The most important line in XFLT's third-quarter webinar was not about yield, spreads, or the loan market. It was a scheduling note. Kimberly Flynn, the fund's CFO, explained that the call had been pulled forward — before the audited fiscal-year report for the period ended September 30 — because "we were eager to get King Street in front of you." That single sentence marks the end of an era for this fund. For years, XFLT's quarterly webinars were Lauren Law's show, an Octagon Credit portfolio manager walking investors through CLO equity distributions and spread compression. This quarter, Octagon is gone from the top of the keyword stack entirely. King Street and Rockford Tower — King Street's dedicated CLO platform, managing nearly $15 billion — sit at the top of the fund's theme list for the first time, alongside tender offer. The change happened quietly at the end of July. Young Choi, Rockford Tower's portfolio manager, described what he found: "we saw several clear opportunities," with the fund's mandate widened "beyond just U.S. loans and CLOs to include global markets and ABS" to give "more flexibility to pursue the best relative value opportunities at any given time." That is a strategic pivot dressed as continuity — and it is genuinely new. Previous quarters' vocabulary was almost entirely domestic CLO mechanics: syndicated loan collateral, repricing activity, reinvestment periods, BB tranches. What replaced it is a rotation framework with three levers: broaden asset classes, optimize holdings within each, then rotate as relative value shifts. In practice Rockford has added synthetic risk transfer as the fund's first ABS position, lifted fixed-rate corporates modestly, cut money-market drag, and consolidated the loan book — issuers down more than 20%, line items down nearly 30%, portfolio spread up about 17 basis points. European CLO debt and equity are now on the menu, which the European CLO keyword captures freshly for this fund.Buying Forty-Cent Dollars, Carefully
The awkward fact at the center of this trust is the price of the asset that generates most of its drama. Flynn put it plainly: “CLO equity is still trading in the $0.40 on the dollar we've yet to see recovery in CLO equity pricing” — Kimberly Flynn, Chief Financial Officer · 2026-11-02. Roughly 40% of the portfolio has sat in CLO equity since inception, and the fund says the asset class currently yields about 19.9%. That is the whole tension in one number. A 40-cent mark on an instrument yielding ~20% is either a fat pitch or a value trap, and the answer depends entirely on whether the two forces pressuring equity — two years of loan repricings compressing collateral spreads, plus this year's loan price volatility — are cyclical or structural. Choi argues the former, and notes the repricing wave has slowed materially: loans trading above par fell from about 40% of the index to the low teens, and new loans are being issued at discounts again. "Cheaper assets against modestly wider liabilities is the combination that's making new CLO deals and the equity in those deals actually work." Note the honesty about the mark. In March, Law hedged hard on the same question, arguing CLO equity “is not a par asset... It is typically sold with a dollar price in the $0.80 range” — Lauren Law, Portfolio Manager · 2026-03-04. The underlying securities' quoted price has clearly kept sliding since — and one prior call's claim that resets and refinancings are "very accretive" for the trust's equity positions now reads as a theme that stopped paying. The more investable framing is dispersion. Spreads backed up from September tights into heavy year-end supply — AAAs in the 120s over SOFR, BBBs mid-200s to low 300s, BBs north of 500 — meaning “dispersion is the defining feature of this market and dispersion favors credit pickers” — Young Choi, Portfolio Manager · 2026-11-02. Choi also flagged structural shifts in the $1.6–1.7 trillion loan market that matter for anyone owning the collateral: documentation has weakened to near-covenant-lite across the board, and CLOs now dominate the buyer base, orphaning loans that fail CLO eligibility tests. Both are reasons the dispersion theme is durable rather than a quarter's talking point.The Discount War, Now With Deadlines
The clearest continuity story is governance, and it has teeth now. In March, pressed on share repurchases given the discount, Flynn was noncommittal: “Obviously, I don't make those decisions alone. That's something that our Fund Board makes” — Kimberly Flynn, Chief Financial Officer · 2026-03-04. By October, the Board had a program.Two more contingent tenders follow, roughly 13 and 25 months out, triggered only if the fund is still trading at a specified discount. Total managed assets of $566 million as of September 30 are already "slightly higher" than today precisely because of that initial tender. The discount management program is now the fund's defining shareholder-relations artifact. And the mechanism did not stick. Flynn conceded the price tightened into the tender close and then re-widened, putting XFLT back where it traded before the offer — while noting the discount is still smaller than that of peer funds that run 90% CLO equity exposure versus XFLT's mixed asset mix of loans, CLO debt and equity. That mix is both ballast and handicap: in a bad CLO equity tape it cushions NAV, and in a good one it lags. The tradeable insight is that XFLT's daily independent NAV has become the sector's transparency benchmark while several peers strike monthly or quarterly.The tender offer provided liquidity for shareholders who have been long-time investors in XFLT and seeking liquidity at NAV were able to exit XFLT in the tender offer... It was for up to 12.5% of the fund's outstanding common shares.